Does UPADACITINIB Cause Lymphoproliferative disorder? 11 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 11 reports of Lymphoproliferative disorder have been filed in association with UPADACITINIB (Rinvoq). This represents 0.0% of all adverse event reports for UPADACITINIB.
11
Reports of Lymphoproliferative disorder with UPADACITINIB
0.0%
of all UPADACITINIB reports
1
Deaths
11
Hospitalizations
How Dangerous Is Lymphoproliferative disorder From UPADACITINIB?
Of the 11 reports, 1 (9.1%) resulted in death, 11 (100.0%) required hospitalization, and 3 (27.3%) were considered life-threatening.
Is Lymphoproliferative disorder Listed in the Official Label?
Yes, Lymphoproliferative disorder is listed as a known adverse reaction in the official FDA drug label for UPADACITINIB.
What Other Side Effects Does UPADACITINIB Cause?
Pain (4,444)
Arthralgia (3,815)
Drug ineffective (3,384)
Covid-19 (2,978)
Rheumatoid arthritis (2,730)
Pain in extremity (2,353)
Fatigue (2,153)
Fall (2,081)
Surgery (2,037)
Therapy interrupted (1,741)
What Other Drugs Cause Lymphoproliferative disorder?
METHOTREXATE (1,392)
INFLIXIMAB (225)
PREDNISOLONE (178)
PREDNISONE (141)
TACROLIMUS (139)
MYCOPHENOLATE MOFETIL (138)
CYCLOPHOSPHAMIDE (136)
AZATHIOPRINE (120)
ADALIMUMAB (98)
CYCLOSPORINE (98)
Which UPADACITINIB Alternatives Have Lower Lymphoproliferative disorder Risk?
UPADACITINIB vs URAPIDIL
UPADACITINIB vs UREA
UPADACITINIB vs URIDINE TRIACETATE
UPADACITINIB vs UROFOLLITROPIN
UPADACITINIB vs URSODIOL